These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The health effects of ecstasy: a literature review. Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005 [TBL] [Abstract][Full Text] [Related]
6. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users. Parrott A Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401 [No Abstract] [Full Text] [Related]
7. [A case of acute psychotic episode after a single dose of ecstasy]. Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M Encephale; 2001; 27(2):198-202. PubMed ID: 11407274 [TBL] [Abstract][Full Text] [Related]
8. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. Sumnall HR; Cole JC; Jerome L J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654 [TBL] [Abstract][Full Text] [Related]
9. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. Soar K; Turner JJ; Parrott AC J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716 [TBL] [Abstract][Full Text] [Related]
10. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Reay JL; Hamilton C; Kennedy DO; Scholey AB J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712 [TBL] [Abstract][Full Text] [Related]
11. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556 [TBL] [Abstract][Full Text] [Related]
12. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Parrott AC J Psychopharmacol; 2005 Jan; 19(1):71-83. PubMed ID: 15671132 [TBL] [Abstract][Full Text] [Related]
13. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine. Karlsen SN; Spigset O; Slørdal L Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478 [TBL] [Abstract][Full Text] [Related]
14. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Butler GK; Montgomery AM Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289 [TBL] [Abstract][Full Text] [Related]
15. Modelling the adverse effects associated with ecstasy use. Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557 [TBL] [Abstract][Full Text] [Related]
16. A review of the acute subjective effects of MDMA/ecstasy. Baylen CA; Rosenberg H Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886 [TBL] [Abstract][Full Text] [Related]
17. From "Male Bonding Rituals" to "Suicide Tuesday": A qualitative study of issues faced by gay male ecstasy (MDMA) users. Klitzman R J Homosex; 2006; 51(3):7-32. PubMed ID: 17135113 [TBL] [Abstract][Full Text] [Related]
18. Evidence for executive deficits among users of MDMA (Ecstasy). Fisk JE; Montgomery C; Murphy P; Wareing M Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532 [TBL] [Abstract][Full Text] [Related]